• John Andros


    Mr. Andros was previously the Senior Director, Global Finance and Planning, Surgical Devices at Covidien. Mr. Andros has more than 20 years of financial experience in the medical device industry with US Surgical, Tyco Healthcare, and Covidien, where he held various management positions. Areas of expertise include financial planning, business analysis, acquisitions & divestitures, profitability and cash flow management, and accounting. Mr. Andros has a BA in Finance from the College of William and Mary and an MBA in Corporate Finance from Pace University. 

    Mederi Therapeutics Inc.
  • Oleg Shikhman


    Mr. Shikhman was previously the Vice President of Product Development and Operations at Interventional Therapies. He has served as Vice President of Operations with Vivatone Hearing Systems. Prior to that Mr. Shikhman held various senior level engineering and project management positions for United States Surgical Corporation. Mr. Shikhman has a BS in Mechanical Engineering from the Odessa Polytechnic Institute in Ukraine, a Masters degree in Engineering Management from the University of Bridgeport and an MBA from the University of Connecticut. He also holds multiple patents in the medical device instrumentation field.

    Mederi Therapeutics Inc.
  • William Reynolds

    Vice President of Reimbursement and Payer Policy

    Mr. Reynolds was previously the Executive Director, Reimbursement & Health Economics for the Olympus Corporation. His 30-year career includes roles in market access for devices and biologics with Genzyme Corp. and Transkaryotic Therapies, as a consultant with Price Waterhouse Coopers, in hospital administration as the Director of Financial Planning, and as a Reimbursement Manager with Blue Cross of Massachusetts. Mr. Reynolds holds a BA in Economics from Westfield State University.

    Mederi Therapeutics Inc.
  • Bob Knarr


    Mr. Knarr joined Mederi as CEO on October 1, 2015. A specialist in medical device growth and development, Mr. Knarr was part of the executive team at US Surgical that drove revenue growth from less than $10 million to more than $1.5 billion. His roles at USSC grew from 1977, as a sales representative, to 1998 as President of North American Operations, he also served as a member of the Board of Directors of USSC. He most recently was a founding partner of JHK investments, a medical device focused venture capital firm led by the founders of US Surgical. Their portfolio of products and companies included interventional cardiology (Angiolink, Jarvik Heart, Interventional Therapies), Cryogen, Biowave pain management products, and Vivatone Hearing Aid Systems.

    Mederi Therapeutics Inc.
Mederi Therapeutics » The Mederi Team » Management Team